GLUCOSE, ANHYDROUS
Cystic Fibrosis-related Diabetes
Children's Hospital of PhiladelphiaSmall moleculeEarly Phase 1Active
CCC
51/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Cystic Fibrosis-related Diabetes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Glargine Insulin University of Minnesota | Phase 3 | BB |
Semaglutide University of Minnesota | Phase 2/3 | B |
Empagliflozin University of Minnesota | Phase 2/3 | B |
Insulin Detemir [Rdna Origin] Nationwide Children's Hospital | Phase 2/3 | CCC |
Metformin University of Kansas Medical Center | Phase 2 | CCC |
Dorzagliatin University of Pennsylvania | Phase 1 | CC |
REPAGLINIDE Arbelaez, Ana Maria | N/A | D |
Same molecule, other indications
GLUCOSE, ANHYDROUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →